I agree to the use of cookies and have read and understood TTP Labtech’s privacy policy.

Resources (146)

Liquid handling

Lorenz, D., et al. (2018). Development and implementation of an HTS-compatible assay for the discovery of selective small-molecule ligands for pre-microRNAs. SLAS DISCOVERY: Advancing Life Sciences R&D

Liquid handling

Foote, P., et al. (2018). High‐Throughput Screening of HECT E3 Ubiquitin Ligases Using UbFluor. Current protocols in chemical biology

Cell-based assays

Koundinya, M., et al. (2018). Dependence on the Pyrimidine Biosynthetic Enzyme DHODH Is a Synthetic Lethal Vulnerability in Mutant KRAS-Driven Cancers. Cell chemical biology

Cell-based assays

Feng, Y., et al. (2018). Hexon and fiber of adenovirus type 14 and 55 are major targets of neutralizing antibody but only fiber-specific antibody contributes to cross-neutralizing activity. Virology

Cell-based assays

Berenguer, J., et al. (2018). Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8. Journal of extracellular vesicles

Cell-based assays

Dobrovolsky, D., et al. (2018). Bruton's Tyrosine Kinase degradation as a therapeutic strategy for cancer. Blood

Cell-based assays

Beyleveld, G., et al. (2018). Nucleolar Relocalization of RBM14 by Influenza A Virus NS1 Protein. mSphere

Cell-based assays

Datta, A., et al. (2018). High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer. Scientific reports

Cell-based assays

Gong, X., et al. (2018). Aurora-A kinase inhibition is synthetic lethal with loss of the RB1 tumor suppressor gene. Cancer discovery

Cell-based assays

Sullivan, N., et al. (2018). Breadth and functionality of varicella-zoster virus glycoprotein-specific antibodies identified after Zostavax vaccination in humans. Journal of virology

Cell-based assays

Michaloglou, C., et al. (2018). Combined Inhibition of mTOR and CDK4/6 Is Required for Optimal Blockade of E2F Function and Long-term Growth Inhibition in Estrogen Receptor–positive Breast Cancer. Molecular cancer therapeutics

Cell-based assays

Oshima, T., et al (2018). Fc engineering of anti-Nectin-2 antibody improved thrombocytopenic adverse event in monkey. PloS one

Interested? Get in touch to start the journey

Find help through our cross-domain support package

Find out where you can see our technologies in action

Get up to speed with our news